Cargando…
Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine
BACKGROUND: l-Alanyl-l-glutamine (AQ) is a functional dipeptide with high water solubility, good thermal stability and high bioavailability. It is widely used in clinical treatment, post-operative rehabilitation, sports health care and other fields. AQ is mainly produced via chemical synthesis which...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291740/ https://www.ncbi.nlm.nih.gov/pubmed/32527330 http://dx.doi.org/10.1186/s12934-020-01369-2 |
_version_ | 1783545967410151424 |
---|---|
author | Zhu, Jiangming Yang, Wei Wang, Bohua Liu, Qun Zhong, Xiaotong Gao, Quanxiu Liu, Jiezheng Huang, Jianzhong Lin, Baixue Tao, Yong |
author_facet | Zhu, Jiangming Yang, Wei Wang, Bohua Liu, Qun Zhong, Xiaotong Gao, Quanxiu Liu, Jiezheng Huang, Jianzhong Lin, Baixue Tao, Yong |
author_sort | Zhu, Jiangming |
collection | PubMed |
description | BACKGROUND: l-Alanyl-l-glutamine (AQ) is a functional dipeptide with high water solubility, good thermal stability and high bioavailability. It is widely used in clinical treatment, post-operative rehabilitation, sports health care and other fields. AQ is mainly produced via chemical synthesis which is complicated, time-consuming, labor-intensive, and have a low yield accompanied with the generation of by-products. It is therefore highly desirable to develop an efficient biotechnological process for the industrial production of AQ. RESULTS: A metabolically engineered E. coli strain for AQ production was developed by over-expressing l-amino acid α-ligase (BacD) from Bacillus subtilis, and inactivating the peptidases PepA, PepB, PepD, and PepN, as well as the dipeptide transport system Dpp. In order to use the more readily available substrate glutamic acid, a module for glutamine synthesis from glutamic acid was constructed by introducing glutamine synthetase (GlnA). Additionally, we knocked out glsA–glsB to block the first step in glutamine metabolism, and glnE–glnB involved in the ATP-dependent addition of AMP/UMP to a subunit of glutamine synthetase, which resulted in increased glutamine supply. Then the glutamine synthesis module was combined with the AQ synthesis module to develop the engineered strain that uses glutamic acid and alanine for AQ production. The expression of BacD and GlnA was further balanced to improve AQ production. Using the final engineered strain p15/AQ10 as a whole-cell biocatalyst, 71.7 mM AQ was produced with a productivity of 3.98 mM/h and conversion rate of 71.7%. CONCLUSION: A metabolically engineered strain for AQ production was successfully developed via inactivation of peptidases, screening of BacD, introduction of glutamine synthesis module, and balancing the glutamine and AQ synthesis modules to improve the yield of AQ. This work provides a microbial cell factory for efficient production of AQ with industrial potential. [Image: see text] |
format | Online Article Text |
id | pubmed-7291740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72917402020-06-12 Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine Zhu, Jiangming Yang, Wei Wang, Bohua Liu, Qun Zhong, Xiaotong Gao, Quanxiu Liu, Jiezheng Huang, Jianzhong Lin, Baixue Tao, Yong Microb Cell Fact Research BACKGROUND: l-Alanyl-l-glutamine (AQ) is a functional dipeptide with high water solubility, good thermal stability and high bioavailability. It is widely used in clinical treatment, post-operative rehabilitation, sports health care and other fields. AQ is mainly produced via chemical synthesis which is complicated, time-consuming, labor-intensive, and have a low yield accompanied with the generation of by-products. It is therefore highly desirable to develop an efficient biotechnological process for the industrial production of AQ. RESULTS: A metabolically engineered E. coli strain for AQ production was developed by over-expressing l-amino acid α-ligase (BacD) from Bacillus subtilis, and inactivating the peptidases PepA, PepB, PepD, and PepN, as well as the dipeptide transport system Dpp. In order to use the more readily available substrate glutamic acid, a module for glutamine synthesis from glutamic acid was constructed by introducing glutamine synthetase (GlnA). Additionally, we knocked out glsA–glsB to block the first step in glutamine metabolism, and glnE–glnB involved in the ATP-dependent addition of AMP/UMP to a subunit of glutamine synthetase, which resulted in increased glutamine supply. Then the glutamine synthesis module was combined with the AQ synthesis module to develop the engineered strain that uses glutamic acid and alanine for AQ production. The expression of BacD and GlnA was further balanced to improve AQ production. Using the final engineered strain p15/AQ10 as a whole-cell biocatalyst, 71.7 mM AQ was produced with a productivity of 3.98 mM/h and conversion rate of 71.7%. CONCLUSION: A metabolically engineered strain for AQ production was successfully developed via inactivation of peptidases, screening of BacD, introduction of glutamine synthesis module, and balancing the glutamine and AQ synthesis modules to improve the yield of AQ. This work provides a microbial cell factory for efficient production of AQ with industrial potential. [Image: see text] BioMed Central 2020-06-11 /pmc/articles/PMC7291740/ /pubmed/32527330 http://dx.doi.org/10.1186/s12934-020-01369-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhu, Jiangming Yang, Wei Wang, Bohua Liu, Qun Zhong, Xiaotong Gao, Quanxiu Liu, Jiezheng Huang, Jianzhong Lin, Baixue Tao, Yong Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine |
title | Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine |
title_full | Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine |
title_fullStr | Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine |
title_full_unstemmed | Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine |
title_short | Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine |
title_sort | metabolic engineering of escherichia coli for efficient production of l-alanyl-l-glutamine |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291740/ https://www.ncbi.nlm.nih.gov/pubmed/32527330 http://dx.doi.org/10.1186/s12934-020-01369-2 |
work_keys_str_mv | AT zhujiangming metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine AT yangwei metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine AT wangbohua metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine AT liuqun metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine AT zhongxiaotong metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine AT gaoquanxiu metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine AT liujiezheng metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine AT huangjianzhong metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine AT linbaixue metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine AT taoyong metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine |